Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Notify me when in stock Drop your email and we'll let you know the moment it's back
After starting and after each dose increase, tirzepatide can cut the peak absorption of an oral contraceptive by more than half, so the label guidance is a non-oral method or added barrier protection for four weeks after starting and four weeks after each increase. It is a first-dose-and-escalation effect, not a permanent block on all oral drugs
Nausea is the most commonly reported early side effect
Purchasers are responsible for complying with all applicable federal, state, and local regulations regarding the handling and use of laboratory research compounds
The potential effects on fetal development and breast milk composition are unknown
